Conference Call Participants Andrew Masuda I'm joined by our President and CEO, Jim Brown; our Chief Financial Officer, Doug Hekking; as well as other executives. Despite this environment, we delivered fourth quarter net sales and diluted EPS above expectations. We ended the year with $330 million in cash and essentially debt-free as we continue to generate strong free cash flow. While 2023 was a year of reengaging with our associate leaders in a live setting and 2024, we'll be doubling down on engaging, tr ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ____________ Commission file number: 001-35024 ______________________ USANA HEALTH SCIENCES, INC. (Exact name of registra ...

Company Participants Conference Call Participants Operator I will now hand you over to your host, Mr. Andrew Masuda to begin today's conference. Thank you. Thanks, Valeria, and good morning everyone. We appreciate you joining us to review our third quarter results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website. As a reminder, during the course of this conference ...

Linda Bolton-Weiser So I'm not sure I'm understanding. So the China promotion that was better than expected occurred in the second quarter and that high gross margin business. So that helps the gross margin. Is that what you're trying to say? Doug Hekking Yes, that's what I'm saying. Linda Bolton-Weiser Okay. So then maybe going forward, we should be a little a little lower in our expectation maybe for gross margin. Doug Hekking Yes. Yes. I think you saw something is probably a little bit better than what w ...

USANA Health Sciences, Inc. (NYSE:USNA) Q1 2023 Earnings Conference Call April 26, 2023 11:00 AM ET Company Participants Andrew Masuda - Director of Investor Relations Kevin Guest - Chief Executive Officer Jim Brown - President Doug Hekking - Chief Financial Officer Walter Noot - Chief Operating Officer Brent Neidig - Chief Officer and Managing Director of China David Mulham - Chief Sales Officer Conference Call Participants Linda Bolton Weiser - D. A. Davidson & Co. Operator Good day and welcome to today’s ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-35024 ______________________________ USANA HEALTH SCIENCE ...

USANA Health Sciences, Inc. (NYSE:USNA) Q4 2022 Earnings Conference Call February 8, 2023 11:00 AM ET Company Participants Andrew Masuda - Investor Relations Kevin Guest - Chairman and Chief Executive Officer Jim Brown - President Doug Hekking - Chief Financial Officer Brent Neidig - Chief Officer and Managing Director, China Conference Call Participants Linda Bolton-Weiser - D.A. Davidson Susan Anderson - Canaccord Genuity Ivan Feinseth - Tigress Financial Partners Operator Good day and welcome to today’s ...

USANA Health Sciences, Inc. (NYSE:USNA) Q3 2022 Earnings Conference Call October 26, 2022 11:00 AM ET Company Participants Andrew Masuda – Investor Relations Kevin Guest – Chief Executive Officer and Chairman of the Board Doug Hekking – Chief Financial Officer Conference Call Participants Linda Bolton-Weiser – D.A. Davidson Operator Hello, and welcome to USANA Health Sciences Third Quarter Earnings Call. My name is Sarah, and I will be your coordinator for today's event. Please note, this conference is bein ...

USANA Health Sciences, Inc. (NYSE:USNA) Q2 2022 Earnings Conference Call July 27, 2022 11:00 AM ET Company Participants Andrew Masuda - Director, IR Kevin Guest - CEO & Chairman Jim Brown - President Doug Hekking - CFO Brent Neidig - Chief Officer & MD, China Walter Noot - COO Conference Call Participants Chris Neamonitis - Jefferies Doug Lane - Lane Research Linda Bolton Weiser - D.A. Davidson Operator Good day and welcome to USANA Health Sciences' Second Quarter Conference Call. Today's conference is bein ...

USANA Health Sciences, Inc. (NYSE:USNA) Q1 2022 Results Conference Call April 27, 2022 11:00 AM ET Company Participants Andrew Masuda - Director of Investor Relations Kevin Guest - Chairman and Chief Executive Officer Doug Hekking - Chief Financial Officer Brent Neidig - Chief Officer and Managing Director of China Jim Brown - President Conference Call Participants Chris Neamonitis - Jefferies Doug Lane - Lane Research Linda Bolton Weiser - D.A. Davidson Operator Good day and welcome to USANA Health Science ...